Fiche publication


Date publication

octobre 2022

Journal

Frontiers in bioengineering and biotechnology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr POUTHIER Fabienne , Dr GINDRAUX Florelle


Tous les auteurs :
Odet S, Solecki L, Meyer C, Weber E, Chatelain B, Euvrard E, Barrabé A, Gualdi T, Parmentier AL, Tatu L, Pouthier F, Louvrier A, Gindraux F

Résumé

The purpose of this pilot porcine study was to explore and illustrate the surgical application of human amniotic membrane (hAM) in an model of medication-related osteonecrosis of the jaw (MRONJ). Five oral and maxillofacial surgeons participated to this study. MRONJ was simulated on porcine mandible specimens. hAM was applied using four different techniques: implantation with complete coverage, implantation with partial coverage, apposition and covering graft material. At the same time, the surgeons evaluated how well the hAM handled and its physical properties during the surgery. Surgeons found that hAM had suitable mechanical properties, as it was easy to detach from the support, handle, bind to the defect and bury. hAM was also found to be strong and stable. The "implantation with complete coverage" and "implantation with partial coverage" techniques were the preferred choices for the MRONJ indication. This study shows that hAM is a graft material with suitable properties for oral surgery. It is preferable to use it buried under the gingiva with sutures above it, which increases its stability. This technical note aims to educate surgeons and provide them with details about the handling of hAM in oral surgery. Two surgical techniques for hAM application in MRONJ were identified and illustrated. hAM handling and physical properties during surgery were reported.

Mots clés

amniotic membrane, ex vivo, oral mucosa, osteonecrosis of the jaw and illustrations, porcine jaw, xenograft

Référence

Front Bioeng Biotechnol. 2022 10 24;10:968346